BL
NVAX icon

BFSG LLC’s Novavax NVAX Stock Holding History

BFSG LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$478 – 660
2024
Q1 		$478 Buy
+100
New +$464 ﹤0.01% 632

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BFSG LLC's NVAX Position: Q2 2024 in Review

BFSG LLC sold out of Novavax (NVAX) in Q2 2024, closing a stake of 100 shares — an estimated $478 sold.

BFSG LLC first reported a position in NVAX in Q1 2024 and held it in 1 quarter. The position peaked at $478 in Q1 2024. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • BFSG LLC reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • BFSG LLC sold 100 Novavax shares in Q2 2024, an estimated $478.
  • BFSG LLC first reported a position in Novavax in Q1 2024 and held it in 1 quarter.
  • BFSG LLC's Novavax position peaked at $478 in Q1 2024.
  • 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on BFSG LLC's 13F filing for Q2 2024, filed 29 Jul 2024.